Evaluation of synergistic combination comprising magnesium orotate, menaquinone-7, and cholecalciferol for management of type 2 diabetes and dyslipidemia.

Verma, Hitesh; Garg, Rajeev

Verma, Hitesh; Garg, Rajeev.

Affiliation

Verma H; IKG Punjab Technical University, KapurthalaIndia, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, PunjabIndia, Overseas R&D Centre, Overseas HealthCare Pvt Ltd., Phillaur, PunjabIndia.
Garg R; IKG Punjab Technical University, KapurthalaIndia, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, PunjabIndia.

Magnes Res ; 33(4): 88-105, 2020 Nov 01.

Article in En | MEDLINE | ID: mdl-33574019

Subject(s)

Cholecalciferol/therapeutic use; Diabetes Mellitus, Experimental/drug therapy; Dyslipidemias/drug therapy; Hypoglycemic Agents/therapeutic use; Orotic Acid/analogs & derivatives; Vitamin K 2/analogs & derivatives; Animals; Cholecalciferol/administration & dosage; Diabetes Mellitus, Experimental/chemically induced; Diabetes Mellitus, Experimental/pathology; Disease Models, Animal; Dyslipidemias/chemically induced; Dyslipidemias/pathology; Hypoglycemic Agents/administration & dosage; Male; Niacinamide; Orotic Acid/administration & dosage; Orotic Acid/therapeutic use; Rats; Rats, Wistar; Streptozocin; Vitamin K 2/administration & dosage; Vitamin K 2/therapeutic use

Key words

Wistar rat; cholecalciferol; dyslipidemia; hyperglycemia; magnesium orotate; menaquinone-7; type 2 diabetes

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orotic Acid / Cholecalciferol / Vitamin K 2 / Diabetes Mellitus, Experimental / Dyslipidemias / Hypoglycemic Agents Type of study: Prognostic_studies / Screening_studies Limits: Animals Language: En Journal: Magnes Res Journal subject: FARMACOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google